. 2005 Oct 25;93(9):1011–1018. doi: 10.1038/sj.bjc.6602823

Table 3. Plasma pharmacokinetics of NU7026 and NU7107 following administration at 20 mg kg⁻¹ i.p. to mice.

Compound	C_max (nmol l⁻¹)	T_max (h)	AUC last (nmol l h⁻¹)	t_1/2 (h)	Cl obs. (l h⁻¹)	V_d (l)
7026	5123	0.083	7349	0.87	0.44	0.55
7107	10390	0.25	12165	0.79	0.11	0.12

Parameters are C_max (maximum concentration), AUC (area under the concentration vs time curve), Cl (clearance), t_1/2 (half-life), V_d (volume of distribution based on the elimination phase).

Table 3. Plasma pharmacokinetics of NU7026 and NU7107 following administration at 20 mg kg−1 i.p. to mice.

Table 3. Plasma pharmacokinetics of NU7026 and NU7107 following administration at 20 mg kg⁻¹ i.p. to mice.